GR3019775T3 - Polyhemoglobin stabilized by purine derivatives and glutathione - Google Patents

Polyhemoglobin stabilized by purine derivatives and glutathione

Info

Publication number
GR3019775T3
GR3019775T3 GR960401155T GR960401155T GR3019775T3 GR 3019775 T3 GR3019775 T3 GR 3019775T3 GR 960401155 T GR960401155 T GR 960401155T GR 960401155 T GR960401155 T GR 960401155T GR 3019775 T3 GR3019775 T3 GR 3019775T3
Authority
GR
Greece
Prior art keywords
glutathione
polyhemoglobin
stabilized
periodate
adenosine
Prior art date
Application number
GR960401155T
Other languages
English (en)
Inventor
Mario Feola
Jan S Simoni
Peter C Canizaro
Original Assignee
Univ Texas Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas Tech filed Critical Univ Texas Tech
Publication of GR3019775T3 publication Critical patent/GR3019775T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
GR960401155T 1989-12-29 1996-04-29 Polyhemoglobin stabilized by purine derivatives and glutathione GR3019775T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45907189A 1989-12-29 1989-12-29
PCT/US1990/007442 WO1991009615A1 (en) 1989-12-29 1990-12-12 Polyhemoglobin stabilized by purine derivatives and glutathione

Publications (1)

Publication Number Publication Date
GR3019775T3 true GR3019775T3 (en) 1996-07-31

Family

ID=23823294

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401155T GR3019775T3 (en) 1989-12-29 1996-04-29 Polyhemoglobin stabilized by purine derivatives and glutathione

Country Status (15)

Country Link
EP (1) EP0507870B1 (el)
JP (1) JP2954347B2 (el)
KR (1) KR0168866B1 (el)
AT (1) ATE136466T1 (el)
AU (1) AU650439B2 (el)
CA (1) CA2072081C (el)
DE (1) DE69026513T2 (el)
DK (1) DK0507870T3 (el)
ES (1) ES2086532T3 (el)
FI (1) FI105256B (el)
GR (1) GR3019775T3 (el)
IE (1) IE73248B1 (el)
NO (1) NO309799B1 (el)
PT (1) PT96398B (el)
WO (1) WO1991009615A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650388A (en) * 1989-11-22 1997-07-22 Enzon, Inc. Fractionated polyalkylene oxide-conjugated hemoglobin solutions
ATE173273T1 (de) * 1991-02-12 1998-11-15 Univ Texas Tech Verbesserter blutersatz
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5900477A (en) * 1992-01-30 1999-05-04 Baxter International, Inc. Use of hemoglobin in the treatment of hemorrhagic shock
US5264555A (en) * 1992-07-14 1993-11-23 Enzon, Inc. Process for hemoglobin extraction and purification
US6242417B1 (en) * 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
WO1996032130A1 (en) * 1995-04-10 1996-10-17 Baxter International Inc. The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
DE60022751T2 (de) * 1999-07-01 2006-07-13 Sysmex Corp. Mittel zur stabilisierung von hämoglobinen
CN116941603A (zh) * 2023-07-21 2023-10-27 浙江康嘉基因技术有限公司 一种新型醛化鸡红细胞的制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4401652A (en) * 1980-12-31 1983-08-30 Allied Corporation Process for the preparation of stroma-free hemoglobin solutions
US4473496A (en) * 1981-09-14 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Intramolecularly crosslinked hemoglobin
US4831012A (en) * 1984-03-23 1989-05-16 Baxter International Inc. Purified hemoglobin solutions and method for making same
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants

Also Published As

Publication number Publication date
DE69026513T2 (de) 1996-09-12
AU650439B2 (en) 1994-06-23
PT96398B (pt) 1998-12-31
NO922551D0 (no) 1992-06-26
FI922937A0 (fi) 1992-06-24
ATE136466T1 (de) 1996-04-15
JP2954347B2 (ja) 1999-09-27
AU7142591A (en) 1991-07-24
DK0507870T3 (da) 1996-06-10
IE904717A1 (en) 1991-07-17
FI922937A (fi) 1992-06-24
FI105256B (fi) 2000-07-14
IE73248B1 (en) 1997-05-21
JPH05504766A (ja) 1993-07-22
CA2072081A1 (en) 1991-06-30
ES2086532T3 (es) 1996-07-01
WO1991009615A1 (en) 1991-07-11
EP0507870B1 (en) 1996-04-10
PT96398A (pt) 1991-10-31
KR0168866B1 (ko) 1999-01-15
CA2072081C (en) 2002-07-30
NO309799B1 (no) 2001-04-02
NO922551L (no) 1992-08-28
KR920703087A (ko) 1992-12-17
EP0507870A4 (en) 1993-08-11
DE69026513D1 (de) 1996-05-15
EP0507870A1 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
GR3019775T3 (en) Polyhemoglobin stabilized by purine derivatives and glutathione
CA2009637A1 (en) Substituted-1,3-oxathiolanes with antiviral properties
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
AU2822889A (en) Macrocyclic compounds
CA2100269A1 (en) Use of 1, 3-Oxathiolane Nucleoside Analogues in the Treatment of Hepatitis B
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
CA2005815A1 (en) Antiviral acyclic nucleoside derivatives
NZ229453A (en) A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
NZ222741A (en) Pharmaceutical compositions containing an interferon and a purine derivative
ZA892284B (en) Novel fluorophosphonate nucleotide derivatives
EP0586381A4 (en) Improved blood substitute
AU8205987A (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
USD318994S (en) Lathe tool or similar article
AU3528689A (en) Antiviral pharmaceutical composition
AU4425589A (en) Nucleoside derivatives
PH27369A (en) Glutaric acid derivatives and preparations thereof
AU611284C (en) 6-substituted acyclicpyrimidine nucleoside derivatives and antiviral agents containing same as active ingredients
AU1590488A (en) 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino-(1,2-a)azepino derivatives and 10-aza, 10-oxa and 10-thia analogues
TH14151EX (th) อนุพันธ์ต่าง ๆ ของอิมิดาโซลที่เป็นตัวต่อต้านฤทธิ์แอนจิโอเทนซิน ii, การเตรียมสารเหล่านี้และการใช้สารเหล่านี้บำบัดโรค